Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 11 - 20 of 34 Projects
Project # Contact PI Funding Organization Fiscal Year
P75 Receptor Modulation for AD: Phase 2a POM/Safety/Exploratory Endpoint Trial
GC-2012768 Longo, Frank Alzheimer's Drug Discovery Foundation 2015
Etanercept in Alzheimer's Disease: a randomised, placebo controlled, double-blind phase 2 trial
GH-2012563 HOLMES, CLIVE Alzheimer's Drug Discovery Foundation 2015
LONG-TERM NICOTINE TREATMENT OF MILD COGNITIVE IMPAIRMENT
1R01AG047992-01A1 NEWHOUSE, PAUL A. NIA 2015
SPHINGOLIPIDS AND INFLAMMATION IN THE DEVELOPMENT AND PROGRESSION OF ALZHEIMER'S
1R01AG049704-01 MIELKE, MICHELLE M NIA 2015
PHASE 1 CLINICAL STUDIES WITH THE GAMMA-SECRETASE MODULATOR, NGP 555 TO ESTABLISH SAFETY, PHARMACOKINETICS, AND BIOMARKER EFFICACY
1R01AG49702-01 KOUNNAS, MARIA ZOE NIA 2015
RESOLVING FACTORS IN Alzheimer's DISEASE
1R21AG048631-01A1 GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER NIA 2015
CLINICAL EVALUATION OF T3D-959 AS A POTENTIAL DISEASE REMEDIAL THERAPEUTIC FOR THE TREATMENT OF ALZHEIMER'S DISEASE
1R44AG49510-01 DIDSBURY, JOHN NIA 2015
STUDIES IN DEMENTIA AND NEURODEGENERATIVE DISEASES
1ZIAAG000975-07 KAPOGIANNIS, DIMITRIOS NIA 2015
MODULATION OF MICRORNA PATHWAYS BY GEMFIBROZIL IN PREDEMENTIA ALZHEIMER DISEASE
3R01AG042419-02S1 JICHA, GREGORY A NIA 2015
CITALOPRAM DECREASES CSF AB: A RANDOMIZED DOSE FINDING TRIAL
5R01AG041502-05 SHELINE, YVETTE I NIA 2015